Study on the Effects of Atacicept in Adults with IgA Nephropathy
Denmark- Participants:18–64 years · 65+ years
- Substances:Atacicept
- Sponsor:Vera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Denmark167 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.
Ongoing investigations into personalized treatment approaches for various cancer types.
Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.
Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.
Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.
Advancing treatment options for patients with moderate to severe skin conditions.
Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.
Important research advancing preventive medicine and infection control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.